These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34061169)

  • 1. Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage.
    Thiele A; Luettges K; Ritter D; Beyhoff N; Smeir E; Grune J; Steinhoff JS; Schupp M; Klopfleisch R; Rothe M; Wilck N; Bartolomaeus H; Migglautsch AK; Breinbauer R; Kershaw EE; Grabner GF; Zechner R; Kintscher U; Foryst-Ludwig A
    Cardiovasc Res; 2022 Aug; 118(11):2488-2505. PubMed ID: 34061169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
    Takahara S; Ferdaoussi M; Srnic N; Maayah ZH; Soni S; Migglautsch AK; Breinbauer R; Kershaw EE; Dyck JRB
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H432-H446. PubMed ID: 33185110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.
    Parajuli N; Takahara S; Matsumura N; Kim TT; Ferdaoussi M; Migglautsch AK; Zechner R; Breinbauer R; Kershaw EE; Dyck JRB
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H879-H884. PubMed ID: 29932770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction.
    Bottermann K; Granade ME; Oenarto V; Fischer JW; Harris TE
    J Cardiovasc Pharmacol Ther; 2021 May; 26(3):289-297. PubMed ID: 33150796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ATGL-mediated lipolysis attenuates β-adrenergic-induced AMPK signaling, but not the induction of PKA-targeted genes, in adipocytes and adipose tissue.
    MacPherson RE; Dragos SM; Ramos S; Sutton C; Frendo-Cumbo S; Castellani L; Watt MJ; Perry CG; Mutch DM; Wright DC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C269-76. PubMed ID: 27357546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.
    Roy PP; D'Souza K; Cuperlovic-Culf M; Kienesberger PC; Touaibia M
    Eur J Med Chem; 2016 Aug; 118():290-8. PubMed ID: 27155760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors.
    Jin J; Huang S; Wang L; Leng Y; Lu W
    Chem Biol Drug Des; 2017 Dec; 90(6):1122-1133. PubMed ID: 28548386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduction of lipid-sourced energy production caused by ATGL inhibition cannot be compensated by activation of HSL, autophagy, and utilization of other nutrients in fish.
    Han SL; Liu Y; Limbu SM; Chen LQ; Zhang ML; Du ZY
    Fish Physiol Biochem; 2021 Feb; 47(1):173-188. PubMed ID: 33245450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose Triglyceride Lipase-Mediated Adipocyte Lipolysis Exacerbates Acute Pancreatitis Severity in Mouse Models and Patients.
    Xie X; Liu Y; Yang Q; Ma X; Lu Y; Hu Y; Zhang G; Ke L; Tong Z; Liu Y; Xue J; Lu G; Li W
    Am J Pathol; 2024 Aug; 194(8):1494-1510. PubMed ID: 38705384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of small-molecule inhibitors targeting adipose triglyceride lipase.
    Mayer N; Schweiger M; Romauch M; Grabner GF; Eichmann TO; Fuchs E; Ivkovic J; Heier C; Mrak I; Lass A; Höfler G; Fledelius C; Zechner R; Zimmermann R; Breinbauer R
    Nat Chem Biol; 2013 Dec; 9(12):785-7. PubMed ID: 24096302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
    Fuchs CD; Radun R; Dixon ED; Mlitz V; Timelthaler G; Halilbasic E; Herac M; Jonker JW; Ronda OAHO; Tardelli M; Haemmerle G; Zimmermann R; Scharnagl H; Stojakovic T; Verkade HJ; Trauner M
    Hepatology; 2022 Jan; 75(1):125-139. PubMed ID: 34387896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL).
    Mayer N; Schweiger M; Fuchs E; Migglautsch AK; Doler C; Grabner GF; Romauch M; Melcher MC; Zechner R; Zimmermann R; Breinbauer R
    Bioorg Med Chem; 2020 Aug; 28(16):115610. PubMed ID: 32690265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of ATGL-mediated breakdown of lipid droplets in microglia alleviates neuroinflammatory and behavioural responses to lipopolysaccharides.
    Robb JL; Boisjoly F; Machuca-Parra AI; Coursan A; Manceau R; Majeur D; Rodaros D; Bouyakdan K; Greffard K; Bilodeau JF; Forest A; Daneault C; Ruiz M; Laurent C; Arbour N; Layé S; Fioramonti X; Madore C; Fulton S; Alquier T;
    Brain Behav Immun; 2025 Jan; 123():315-333. PubMed ID: 39326768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.
    Bottermann K; Kalfhues L; Nederlof R; Hemmers A; Leitner LM; Oenarto V; Nemmer J; Pfeffer M; Raje V; Deenen R; Petzsch P; Zabri H; Köhrer K; Reichert AS; Grandoch M; Fischer JW; Herebian D; Stegbauer J; Harris TE; Gödecke A
    Basic Res Cardiol; 2022 Oct; 117(1):48. PubMed ID: 36205817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice.
    Schweiger M; Romauch M; Schreiber R; Grabner GF; Hütter S; Kotzbeck P; Benedikt P; Eichmann TO; Yamada S; Knittelfelder O; Diwoky C; Doler C; Mayer N; De Cecco W; Breinbauer R; Zimmermann R; Zechner R
    Nat Commun; 2017 Mar; 8():14859. PubMed ID: 28327588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic tone dictates the impact of lipolysis on FABP4 secretion.
    Prentice KJ; Lee A; Cedillo P; Inouye KE; Ertunc ME; Riveros JK; Lee GY; Hotamisligil GS
    J Lipid Res; 2023 Jun; 64(6):100386. PubMed ID: 37172691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).
    Schreiber R; Xie H; Schweiger M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):880-899. PubMed ID: 30367950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: a novel mechanistic insight into progressive obesity.
    Dai Z; Qi W; Li C; Lu J; Mao Y; Yao Y; Li L; Zhang T; Hong H; Li S; Zhou T; Yang Z; Yang X; Gao G; Cai W
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):123-34. PubMed ID: 23850519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing.
    Camell CD; Sander J; Spadaro O; Lee A; Nguyen KY; Wing A; Goldberg EL; Youm YH; Brown CW; Elsworth J; Rodeheffer MS; Schultze JL; Dixit VD
    Nature; 2017 Oct; 550(7674):119-123. PubMed ID: 28953873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.